Meeting Place :
Certosa di Pontignano, Siena

PROGRAMME

14.00 welcome with a light snack

AP-1 and transcription (Chairman Angel)

15.00 Alessio Zippo (Siena) : MYC and PIM1 regulate FRA1 transcription by modifying the chromatin at the E box element

15.20 Markus Winter (Jena / Karlsruhe): Translational regulation of an AP-1 co-activator

15.40 Laura Casalino (Napoli): Fra1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription

16.00 Maya Hobeika (Lyon): Sparc expression and its regulation by AP-1 in human neuroblastoma cell lines

16.20 Coffee break

AP-1 and cancer (Agi Grigoriadis)

16.40 Jochen Hess (Heidelberg): Novel tumor-associated genes in epithelial carcinogenesis

17.00 Christoffer Gebhardt (Heidelberg): RAGE-dependent signalling in skin carcinogenesis

17.20 Lijian Hui (Vienna): Functions of MAPKs and AP-1 in liver cancer development

17.40 Helen Morrison (Jena / Karlsruhe): CPI 17

18.00 Ulrike Merkel (Jena / Karlsruhe): Ezrin function in the activation of RAS

18.20 Pasquale Verde (Napoli): Novel AP-1-dependent regulatory targets in response to the RAS oncogene.

18.40 Meeting with RTN fellows

20.00 Dinner

AP-1 inflammation, tumor and aging (Chairman van Dam)

09.00 Maria Munoz (Paris) : Antitumoral effect of cannabinoids : possible involvement of AP1

09.20 Latifa Bakiri (Vienna): Functions of Fos phosphorylation in bone development and Tumorigenesis

09.40 Hans van Dam (Leiden): AP-1 and DNA damage responses

10.00 Wolfgang Breitwieser (Manchester): Role of ATF2/ATF7 in cell survival

10.20 Coffee break

AP-1 inflammation, tumor and aging (Chairman Castellazzi)

10.40 Juan Guinea Viniegra (Vienna): How does AP-1 control epidermal inflammation and tumor formation?

11.00 Lionel Gresh (Vienna): Functions of AP-1 in colon inflammation and cancer

11.20 Peter Hasselblatt (Vienna) : AP-1 in liver inflammation and cancer

11.40 Gaelle Laurent (Paris) : Role of junD in metabolic dysfunction and premature aging

12.30 lunch

AP-1 and differentiation (Chairman Wagner)

14.00 Dan Weekes (London): Growth control of osteoblasts and chondrocytes by c-Fos

14.20 Agi Grigoriadis (London): ES cell differentiation to bone cell lineages

14.40 Aline Bozec (Vienna): A novel mechanism to control bone mass by Fra-2

15.00 Mimmo Migliorini (Vienna): AP-1 and tumor suppression in ES cell
Differentiation

15.20 Axel Szabowski (Heidelberg): JNK-dependent fibroblast-derived factors controlling keratinocyte stratification and terminal differentiation

15.40 Julien Ackermann (Manchester): Role of ATF2 in the hindbrain

16.00 Coffee break

AP-1 and signalling (Chairman Jones)

16.20 Bart Baan (Leiden): ATF2 and insulin-signaling

16.40 Christine Heilbock (Jena / Karlsruhe): The cytoplasmic tail of CD44 in the nucleus

17.00 Sandrine Evellin (Siena): FRA1 controls endothelial cell adhesion

17.20 Ahmad Salameh (Siena): JNK signalling in endothelial cell survival

17.40 Steve Lyons (Manchester): Role of ATF2 in contact inhibition of growth

18.00 Amélie Sabine (Lyon) : AP-1 expression in VEGF-activated HUVEC

18.20 Round table: AP-1 present, past, and future (Chair Herrlich and Yaniv)

20.00 Dinner

List of participants

Ackermann Julien
Angel Peter
Bakiri Latifa
Bardelli Monia
Bart Baan
Bluteau Gilles
Carlo Scala
Casalino Laura
Castellazzi Marc
D'angelo Anna
Del Tordello Elena
Evellin Sandrine
Galvagni Federico
Gebhardt Christoffer
Gimigliano Anna
Gresh Lionel
Grigoriadis Agi
Gubbay Oliver
Guinea Jean
Hansen Soeren
Hasselblatt Peter
Herrlich Peter
Hess Jochen
Hobeika Maya
Hui Lijan
Imperatore Francesco
James Dominic
Jones Nicholas
Kassel Olivier
Laurent, Gaelle
Lyons Steve
Maier Yana
Mechta-Grigoriou Fatima
Migliorini Domenico
Munoz-Caffarel Maria
Oliviero Salvatore
Orlandini Maurizio
Pennacchini Susanna
Rocchigiani Marina
Sabine Amelie
Salame’ Ahmad
Seafini Riccardo
Szabowski Axel
Talotta Francesco
Van Dam Hans
Verde Pasquale
Wagner Erwin
Weekes Daniel
Winter Marcus
Wolfgang Breitwieser
Yaniv Moshe
Zippo Alessio